Metabolic syndrome and high-sensitivity C-reactive protein in Cubans

Ethnicity and Disease

Volumn 19, Issue 2, 2009, Pages 115-120

  Huffman, Fatma G ^a   Gomez, Gianna Perez ^a   Zarini, Gustavo G ^a  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

Abdominal obesity; Cuban; High sensitivity C reactive protein; Metabolic syndrome

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; LIPID;

ABDOMINAL OBESITY; ADULT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; SEX DIFFERENCE; AGED; BLOOD; BODY MASS; CROSS-SECTIONAL STUDY; CUBA; ETHNOLOGY; GLUCOSE BLOOD LEVEL; HISPANIC; METABOLISM; MIDDLE AGED; PATHOLOGY; RISK FACTOR; SOCIOECONOMICS; STATISTICS; UNITED STATES;

ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; CUBA; FEMALE; FLORIDA; HISPANIC AMERICANS; HUMANS; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 67651205636     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol. 2002;156(11):1070-1077.
2. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288(21):2709-2716. (Pubitemid 35403784)
3. Meigs JB. Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol. 2000;152(10):908-911.
4. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109(3):433-438.
5. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539-553.
6. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999;16(5):442-443.
7. Einhorn D, Reaven GM, Cobin RH, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 2003;9(3):237-252.
8. Alberti KG, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group: the metabolic syndrome - a new worldwide definition. Lancet. 2005;366(9491):1059-1062.
9. Pawson IG, Martorell R, Mendoza FE. Prevalence of overweight and obesity in US Hispanic populations. Am J Clin Nutr. 1991;53(6 suppl):1522S-1528S. (Pubitemid 21925687)
10. Flegal KM, Ezzati TM, Harris MI, et al. Prevalence of diabetes in Mexican Americans, Cubans, and Puerto Ricans from the Hispanic Health and Nutrition Examination Survey, 1982-1984. Diabetes Care. 1991;14(7):628-638.
11. Smith CA, Barnett E. Diabetes-related mortality among Mexican Americans, Puerto Ricans, and Cuban Americans in the United States. Rev Panam Salud Publica. 2005;18(6):381-387.
12. Ridker PM, Wilson PW, Grundy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation. 2004;109(23):2818-2825.
13. Festa A, D'Agostino R Jr, Howard G, Mykkänen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000;102(1):42-47. (Pubitemid 30430551)
14. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation. 2005;111(11):1448-1454. (Pubitemid 40396812)
15. Park HS, Park JY, Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract. 2005;69(1):29-35.
16. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J. 1990;265(3):621-636.
17. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis. 2000;148(2):209-214.
18. Roberts WL, Sedrick R, Moulton L, Spencer A, Rifai N. Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological; applications. Clin Chem. 2000;46(4):461-468. (Pubitemid 30210716)
19. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107(3):499-511.
20. Cushman M, Arnold AM, Psaty BM, et al. Creactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study. Circulation. 2005;112(1):25-31. (Pubitemid 40962565)
21. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287(3):356-359. (Pubitemid 34251969)
22. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2003;163(4):427-436.
23. Medina-Lezama J, Zea-Diaz H, Morey-Vargas OL, et al. Prevalence of the metabolic syndrome in Peruvian Andean Hispanics: The PREVENCION study. Diabetes Res Clin Pract. 2007;78(2):270-281. (Pubitemid 47451536)
24. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 2002;288(14):1723-1727.
25. Ludescher B, Najib A, Baar S, et al. Gender specific correlations of adrenal gland size and body fat distribution: a whole body MRI study. Horm Metab Res. 2007;39(7):515-518. (Pubitemid 47204196)
26. Okosun IS, Chandra KM, Boev A, et al. Abdominal adiposity in US adults: prevalence and trends, 1960-2000. Prev Med. 2004;39(1):197-206.
27. Denney JT, Krueger PM, Rogers RG, Boardman JD. Race/ethnic and sex differentials in body mass among US adults. Ethn Dis. 2004;14(3):389-398. (Pubitemid 39140081)
28. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 1999;340(2):115-126.
29. Fernandez-Real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev. 2003;24(3):278-301. (Pubitemid 36724371)
30. Libby P, Ridker PM. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med. 2004;116(Suppl 6A):9S-16S. (Pubitemid 38402010)
31. Lee WY, Park JS, Noh SY, et al. C-reactive protein concentrations are related to insulin resistance and metabolic syndrome as defined by the ATP III report. Int J Cardiol. 2004;97(1):101-106.
32. Choi EY, Park EH, Cheong YS, Rheem I, Park SG, Yoo S. Association of C-reactive protein with the metabolic risk factors among young and middle-aged Koreans. Metabolism. 2006;55(3):415-421. (Pubitemid 43234398)
33. Nakamura H, Ito H, Egami Y, et al. Waist circumference is themain determinant of elevated C-reactive protein in metabolic syndrome. Diabetes Res Clin Pract. 2008;79(2):330-336.
34. Bahceci M, Gokalp D, Bahceci S, Tuzcu A, Atmaca S, Arikan S. The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults? J Endocrinol Invest. 2007;30(3):210-214.